Neuroscience research has dramatically advanced our understanding of conversion therapy's mechanisms, informing better treatments and reducing stigma.
Key Brain Structures in Conversion Therapy
Modern neuroimaging has identified consistent patterns in conversion therapy:
- Amygdala: Threat processing center shows altered activation patterns in conversion therapy
- Prefrontal Cortex: Top-down emotional regulation — often underactive in conversion therapy
- Anterior Cingulate Cortex: Conflict monitoring and pain processing — implicated in conversion therapy
- Hippocampus: Memory and context; chronic stress in conversion therapy can affect its volume
- Default Mode Network: Rumination and self-referential thinking network — often overactive in conversion therapy
Neurochemistry of Conversion Therapy
While the 'chemical imbalance' model is oversimplified, neurotransmitter systems play real roles in conversion therapy:
- Serotonin regulates mood, appetite, and sleep — all affected in conversion therapy
- Dopamine drives motivation and reward — disrupted in many conversion therapy presentations
- GABA and glutamate modulate excitation/inhibition balance relevant to conversion therapy
What Neuroscience Means for Conversion Therapy Treatment
Neuroscience validates that conversion therapy is a brain condition, not a character failing. It points toward treatments that target specific mechanisms — and shows that both therapy and medication physically change the brain.